Submit Deal

Submit Deal

Cover Image Kyle Gano

Kyle Gano

Chief Business Development and Strategy Officer at NEUROCRINE BIOSCIENCES

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 48 M

Avg. Deal Size£ 48 M

Market Context

Sort

30 Aug 2022|United Kingdom|Pharmaceuticals

Target: DIURNAL GROUP PLC

Bidder: NEUROCRINE BIOSCIENCES

8 Service Providers

5 Target | 3 Bidder

36 Dealmakers

12 Target | 24 Bidder

£ 48 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite